• An Early-Stage THx, Dx & Device Focus:

    Welcome to the site formerly known as [Colorado] Life Science Deal Flow. This new version looks at the biopharma world primarily from an early-stage financing perspective. Be certain to visit our companion site, a FREE Venture Capital dBase, OnBioVC.com, and subscribe by email or RSS.
  • SEARCH the Life Science Deal Flow ARCHIVE

  • business strategy life science

If memory serves me correctly I have waxed on in the past about my affinity for Genetic Engineering News and often highlighted the journal when a Colorado company ended up in print there. Well the love story continues with the 15 November issue where Carol Potera composed a three-page treatise on the Colorado Science + [...]

MycoLogics, Inc., an innovative biotechnology company specializing in the development of novel therapeutic and prophylactic vaccines, announced that its prophylactic vaccine against coccidioidomycosis, also known as San Joaquin Valley Fever (SJVF), demonstrated statistically significant proof-of-concept results in an animal (murine, n=39) model assay. The animal model data demonstrated the low-dose efficacy of MycoLogics’ proprietary [...]

It is often communicated that the entrepreneur an angel or VC is investing in may carry a superior gravitas than the widget itself, “We invest in people not ideas.”
Well Dr. Claude Selitrennikoff, Ph.D., CEO and founder of MycoLogics, Inc. is that serial entrepreneur packing both a track record of success in business acumen and scientific [...]

  

to top of page...


 
  • The Latest LSDF Activity

    September 2010
    M T W T F S S
    « Aug    
     12345
    6789101112
    13141516171819
    20212223242526
    27282930  
  • Search the LSDF Archive

  • Your Advert Can Go Here!

    Find out how, email: arubenstein@rnaventures.com